Dan Karlin
Chief Medical Officer, Definium Therapeutics.
Companies
- Definium TherapeuticsBoard member Sep 29, 2026 to now1
- Definium TherapeuticsChief Medical Officer Jan 10, 2022 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Definium Therapeutics DFTX792,846 shares3$27.2M at $34.31Sep 25, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 25, 2026Sold 10,853 shares at $36.57 of Definium Therapeutics3
- Sep 14, 2026Granted 200,000 shares of Definium Therapeutics4
- Aug 12, 2026Granted 100,000 shares of Definium Therapeutics5
- Jun 25, 2026Sold 10,035 shares at $45.03 of Definium Therapeutics6
- Jun 22, 2026Granted 100,000 shares of Definium Therapeutics7
- Mar 25, 2026Sold 8,018 shares at $18.47 of Definium Therapeutics8
- Feb 3, 2026Granted 150,000 shares of Definium Therapeutics9
- Dec 26, 2025Sold 5,600 shares at $13.15 of Definium Therapeutics10
- Sep 25, 2025Sold 7,704 shares at $9.77 of Definium Therapeutics11
- Jun 25, 2025Sold 7,848 shares at $6.80 of Definium Therapeutics12
- Mar 25, 2025Sold 6,836 shares at $6.74 of Definium Therapeutics13
- Mar 12, 2025Granted 115,000 shares of Definium Therapeutics14
- Dec 26, 2024Sold 6,643 shares at $7.43 of Definium Therapeutics15
- Sep 25, 2024Sold 6,871 shares at $5.98 of Definium Therapeutics16
- Jun 25, 2024Sold 6,925 shares at $7.22 of Definium Therapeutics17
- Mar 25, 2024Sold 6,578 shares at $9.50 of Definium Therapeutics18
- Dec 26, 2023Sold 6,774 shares at $3.63 of Definium Therapeutics19
- Sep 25, 2023Sold 3,240 shares at $3.58 of Definium Therapeutics20
- Sep 25, 2023Sold 3,678 shares at $3.57 of Definium Therapeutics20
- Jun 27, 2023Sold 2,963 shares at $3.21 of Definium Therapeutics21
- Jun 27, 2023Sold 3,820 shares at $3.19 of Definium Therapeutics21
- Mar 14, 2023Granted 125,000 shares of Definium Therapeutics22
- Mar 1, 2023Sold 3,577 shares at $3.51 of Definium Therapeutics23
- Dec 21, 2022Sold 1,211 shares at $2.69 of Definium Therapeutics24
- Oct 27, 2022Sold 644 shares at $3.00 of Definium Therapeutics25
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARDefinium Therapeutics, Board member
- 2
- 3
- 4SEC EDGARForm 4 filed Sep 14, 2026
- 5SEC EDGARForm 4 filed Aug 12, 2026
- 6SEC EDGARForm 4 filed Jun 26, 2026
- 7SEC EDGARForm 4 filed Jun 22, 2026
- 8SEC EDGARForm 4 filed Mar 26, 2026
- 9SEC EDGARForm 4 filed Feb 5, 2026
- 10SEC EDGARForm 4 filed Dec 29, 2025
- 11SEC EDGARForm 4 filed Sep 26, 2025
- 12SEC EDGARForm 4 filed Jun 26, 2025
- 13SEC EDGARForm 4 filed Mar 26, 2025
- 14SEC EDGARForm 4 filed Mar 13, 2025
- 15SEC EDGARForm 4 filed Dec 27, 2024
- 16SEC EDGARForm 4 filed Sep 25, 2024
- 17SEC EDGARForm 4 filed Jun 25, 2024
- 18SEC EDGARForm 4 filed Mar 26, 2024
- 19SEC EDGARForm 4 filed Dec 26, 2023
- 20SEC EDGARForm 4 filed Sep 25, 2023
- 21SEC EDGARForm 4 filed Jun 27, 2023
- 22SEC EDGARForm 4 filed Mar 17, 2023
- 23SEC EDGARForm 4 filed Mar 2, 2023
- 24SEC EDGARForm 4 filed Dec 22, 2022
- 25SEC EDGARForm 4 filed Oct 27, 2022